Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
In Fintech news this week… 🔹 UnivaPay Launches EMV 3-D Secure, Improving…
Fujitsu Ltd. announced on the 6th that by combining the Hirosaki Health…
Astellas Pharma and YASKAWA Electric have agreed to form a joint venture.…
Microsoft has introduced Dragon Copilot. It's the first voice AI assistant for…
Zapath Inc., which develops industry support services specializing in private practice clinics,…
KELA Japan, part of the Israeli cyber threat intelligence firm KELA, announced…
アカウントにサインインする